Pre-Clinical and Early Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (SINE) Exportin 1 (XPO1) Antagonist Selinexor (KPT-330) in Patients with Platinum Resistant/Refractory Ovarian Cancer (OvCa)

Pre-Clinical and Early Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (SINE) Exportin 1 (XPO1) Antagonist Selinexor (KPT-330) in Patients with Platinum Resistant/Refractory Ovarian Cancer (OvCa)

Learn More